[The beta-adrenergic blocking and antiarrhythmic activities of metabolites of befunolol hydrochloride (author's transl)].
D000319:Adrenergic beta-Antagonists / Q000378:metabolism*; D000779:Anesthetics, Local; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000378:metabolism*; D001572:Benzofurans / Q000378:metabolism / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D004837:Epinephrine / Q000037:antagonists & inhibitors; D005260:Female; D006168:Guinea Pigs; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D008297:Male; D010042:Ouabain / Q000037:antagonists & inhibitors; D011412:Propanolamines / Q000378:metabolism* / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D014599:Uterus / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D000779:Anesthetics, Local; D000889:Anti-Arrhythmia Agents; D001572:Benzofurans; D011412:Propanolamines; C006034:befunolol; D010042:Ouabain; D011433:Propranolol; D007545:Isoproterenol; D004837:Epinephrine